PROW and IWHLDA present the GUIDE on:
CD40
Authors: John Gordon; Anita Challa; John Pound
Reviewer: Randolph J. Noelle
OVERVIEW
MOLECULAR FAMILIES
 
Families in which CD40 is a member
ALTERNATE NAMES
 
Bp50
MAJOR LINKS
 
NCBI LocusLink Record: 958
Mendelian Inheritance in Man (OMIM): 109535
SwissProt annotated protein record: P25942
AUTHOR'S ADDITIONAL INSIGHTS
 
Intriguing question of different epitopes displaying differential functions. Is there another ligand(s)?
Signal transduction pathways engaged appear different at different stages of B cell differentiation
Plays a central role in the regulation of cell-mediated immunity as well as antibody mediated immunity**
SYSTEM VIEW
DISEASE RELEVANCE / FUNCTION IN INTACT
 
Central to T cell dependent (TD)-responses
May influence survival of B cell lymphomas
May be an important target for the control of graft rejection, T and antibody mediated autoimmune diseases**
CELLULAR FUNCTION
 
On B cells, involved in growth, differentiation, and isotype-switching
Potent rescue signal from apoptosis in germinal center B cells
Promotes cytokine production in macrophages and dendritic cells
Up-regulates adhesion molecules on dendritic cells and keratinocytes
Stimulates growth arrest in epithelial cells
CELLULAR EXPRESSION
 
B cells including pro-B through to plasma cells (although weak on latter)
Basal epithelial cells plus epithelial cell carcinomas
Macrophages
Follicular dendritic cells
Endothelial cells
Fibroblasts
Keratinocytes
Interdigitating cells
CD34+ hemopoietic cell progenitors also positive
GENE
TRANSCRIPTION REGULATING MOLECULES
 
- No information
TRANSCRIPT
POST-TRANSCRIPTIONAL MODIFICATION
 
No evidence of differentially spliced products
PROTEIN
BIOCHEMICAL ACTIVITY
 
- No information
PROTEIN SEQUENCE LINKS
 
SwissProt annotated protein record: P25942
PROTEIN SEQUENCE ANNOTATION
 
Single chain type I transmembrane molecule
Cysteine-rich extracellular domain of 193 amino acids, a transmembrane region of 22 hydrophobic residues, and a cytoplasmic region of 42 amino acids
Cytoplasmic region appears to contain two distinct functional domains (Goldstein and Watts 1996)
PROTEIN PHYSICAL PROPERTIES
 
| CELL TYPE | MW UNREDUCED | MW REDUCED | Comment |
| B lymphocytes |
(85 kDa dimers) |
48 kDa |
|
POST-TRANSLATIONAL MODIFICATION
 
Glycosylated: 48 kDa glycoprotein appearing as 39 kDa post-deglycosylation
Phosphorylated on serine/threonine residues. No tyrosine phosphorylation
MOLECULAR INTERACTIONS
SUBSTRATES
 
- No information
ENZYME FOR WHICH THIS IS A SUBSTRATE
 
- No information
OTHER LIGANDS AND ASSOCIATED MOLECULES
 
| MOLECULE | COMMENT |
| CD40L |
Inducible member of TNF-family of molecules on TH cells |
REFERENCES
REVIEWS
 
1. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, Van Kooten C, Liu YJ, Rousset F and Saeland S. 1994. The CD40 antigen and its ligand. Annu Rev Immunol 12:881-922 PubMed
2. Foy TM, Aruffo A, Bajorath J, Buhlmann JE and Noelle RJ. 1996. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 14:591-617 PubMed
3. Gordon J. 1995. CD40 and its ligand: central players in B lymphocyte survival, growth, and differentiation. Blood Rev 9:53-56 PubMed
4. Gordon J, Katira A, Holder M, MacDonald I and Pound J. 1994. Central role of CD40 and its ligand in B lymphocyte responses to T-dependent antigens. Cell Mol Biol (Noisy-le-grand) 40:1-13 PubMed
PRIMARY CITATIONS
 
5. Clark EA and Ledbetter JA. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci U S A 83:4494-4498 PubMed
6. Goldstein MD and Watts TH. 1996. Identification of distinct domains in CD40 involved in B7-1 induction or growth inhibition. J Immunol 157:2837-2843 PubMed
7. Paulie S, Ehlin-Henriksson B, Mellstedt H, Koho H, Ben-Aissa H and Perlmann P. 1985. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol Immunother 20:23-28 PubMed
WWW RESOURCES
 
* indicates amended by reviewer, ** indicates added by reviewer
Portions copyright by Garland Press and by the International Workshops on Human Leukocyte Differentiation Antigens; used with permission
Modified 12/01/99 mpr@mail.nih.gov